middl
east
respiratori
syndrom
mer
viral
respiratori
diseas
first
identifi
saudi
arabia
case
continu
detect
middl
east
case
detect
elsewher
either
infect
middl
east
part
chain
transmiss
origin
middl
east
diseas
due
infect
middl
east
respiratori
syndrom
coronaviru
previous
known
novel
coronaviru
human
infect
thought
follow
exposur
infect
camel
transmiss
primarili
healthcar
set
march
world
health
organ
notifi
case
infect
global
includ
apart
epidemiolog
cluster
diagnost
test
littl
clinic
distinguish
infect
sever
viral
respiratori
infect
sever
acut
respiratori
syndrom
influenza
nucleic
acid
test
nat
prefer
method
detect
suitabl
specimen
test
includ
lower
respiratori
tract
sampl
lrt
nasopharyng
swab
oropharyng
swab
nasal
wash
nasal
aspir
lrt
sampl
shown
contain
highest
viral
load
possibl
due
viru
tropism
lrt
confirm
use
polymeras
chain
reaction
assay
requir
posit
result
least
two
differ
specif
target
genom
use
valid
assay
posit
result
one
specif
target
genom
plu
sequenc
confirm
separ
viral
genom
nucleic
acid
sequenc
amplicon
also
recommend
discord
result
differ
confirm
specif
target
import
laboratori
develop
technic
capabl
accur
promptli
identifi
implement
appropri
infect
control
isol
procedur
reduc
potenti
transmiss
aid
rapid
epidemiolog
investig
extern
qualiti
assess
program
essenti
tool
monitor
diagnost
profici
laboratori
provid
result
allow
implement
improv
test
therebi
strengthen
global
capabl
reduc
spread
initi
singl
round
profici
test
program
ptp
detect
pcr
conduct
first
half
royal
colleg
pathologist
australasia
qualiti
assur
program
rcpaqap
identifi
laboratori
countri
six
region
potenti
particip
one
hundr
two
laboratori
confirm
interest
subsequ
confirm
abil
receiv
panel
total
laboratori
locat
differ
countri
return
result
particip
ptp
tabl
addit
verif
step
introduc
ensur
laboratori
document
permit
place
requir
import
materi
countri
profici
test
pt
panel
consist
specimen
made
nine
specimen
inactiv
gamma
irradi
kgi
human
coronaviru
human
coronaviru
neg
control
specimen
well
two
synthet
specimen
j
k
contain
vitro
rna
transcript
rcpaqap
use
similar
transcript
previou
pt
panel
shown
safe
stabl
design
transcript
base
complet
genom
sequenc
human
betacoronaviru
genbank
access
number
follow
five
region
genom
includ
two
synthet
specimen
region
upstream
e
protein
gene
upe
cover
nucleotid
nucleotid
open
read
frame
start
nucleotid
region
open
read
frame
start
nucleotid
well
two
region
one
rna
polymeras
rdrp
start
nucleotid
anoth
nucleocapsid
n
protein
gene
start
nucleotid
length
nucleotid
respect
five
rna
transcript
design
yield
posit
result
assay
origin
publish
corman
et
form
basi
interim
test
middl
east
respiratori
syndrom
coronaviru
specimen
j
contain
five
rna
transcript
whilst
specimen
k
contain
singl
transcript
cover
upe
design
challeng
particip
sampl
k
would
yield
equivoc
result
confirmatori
test
initi
screen
would
return
neg
specimen
provid
lyophil
test
homogen
stabil
homogen
confirm
signific
sampl
degrad
detect
storag
day
subsequ
day
strain
use
provid
public
health
england
coronavirus
includ
panel
prepar
victorian
infecti
diseas
refer
laboratori
vidrl
melbourn
victoria
australia
follow
gamma
irradi
virus
inactiv
confirm
viral
rna
quantifi
use
rel
measur
concentr
target
determin
gener
standard
curv
use
set
primer
quantifi
genom
equival
ge
copi
per
millilitr
three
extern
refere
laboratori
confirm
sampl
characterist
particip
request
test
specimen
pt
panel
confirm
presenc
confirm
presenc
hcov
hcov
present
particip
laboratori
assess
capac
correctli
analyz
specimen
use
exist
pcr
detect
protocol
reagent
perform
qualit
correct
respons
assign
basi
report
expect
result
eg
rule
hcov
confirm
present
identifi
human
coronaviru
perform
assess
separ
detect
detect
identif
hcov
result
submit
synthet
specimen
j
k
score
particip
like
obtain
vari
result
depend
gene
region
pcr
marker
use
test
laboratori
particular
particip
perform
test
accord
assay
develop
unit
state
center
diseas
control
prevent
us
cdc
would
expect
neg
result
specimen
j
assay
target
region
n
gene
differ
region
use
design
vitro
rna
transcript
includ
specimen
specimen
includ
could
provid
interest
inform
regard
particip
laboratori
handl
equivoc
test
result
overal
laboratori
correctli
report
presenc
absenc
nine
score
specimen
figur
addit
laboratori
correctli
report
presenc
absenc
score
specimen
whilst
least
two
discord
result
tabl
absenc
neg
control
sampl
specimen
correctli
report
particip
tabl
five
particip
report
result
three
laboratori
report
result
specimen
unknown
reason
larg
proport
particip
report
limit
capabl
test
human
coronavirus
account
variabl
perform
assess
separ
detect
detect
identif
hcov
laboratori
return
result
regard
hcov
correctli
confirm
rule
presenc
hcov
nine
specimen
tabl
correctli
identifi
two
hcov
includ
specimen
b
specimen
c
specimen
h
summari
perform
laboratori
specimen
present
tabl
pt
panel
includ
dilut
seri
specimen
e
f
g
cover
rna
concentr
rang
particip
report
correct
posit
result
specimen
rna
concentr
rang
particip
report
correct
posit
result
four
specimen
includ
specimen
lowest
viral
load
tabl
laboratori
confirm
presenc
specimen
j
contain
five
rna
transcript
specimen
seven
laboratori
rule
presenc
eight
particip
specifi
specimen
k
contain
one
rna
transcript
laboratori
report
presenc
particip
rule
specifi
presenc
respect
tabl
particip
laboratori
test
specimen
pt
panel
presenc
absenc
gene
target
use
particip
confirm
rule
presenc
specimen
upe
n
rdrp
tabl
particip
follow
variou
protocol
confirm
rule
presenc
examin
set
gene
target
use
show
particip
either
follow
interim
test
middl
east
respiratori
syndrom
coronaviru
assay
develop
us
protocol
recommend
initi
screen
assay
gene
target
upe
subsequ
confirm
one
pcr
assay
gene
target
us
cdc
accord
two
recommend
particip
perform
least
two
pcr
assay
per
specimen
confirm
rule
presenc
figur
pcr
commonli
use
pcr
method
averag
particip
use
method
initi
screen
assay
confirmatori
second
assay
respect
particip
perform
three
pcr
assay
includ
convent
pcr
assay
well
nest
heminest
assay
test
regimen
commonli
use
pcr
platform
includ
abi
pcr
system
particip
roch
lightcycl
particip
pcr
system
particip
qiagen
nine
particip
stratagen
system
five
particip
major
particip
laboratori
reli
manual
rna
extract
use
qiagen
qiaamp
viral
rna
mini
kit
particip
follow
autom
system
biomerieux
nuclisen
easymag
roch
magna
pure
system
use
five
particip
laboratori
respect
rang
manual
rna
extract
system
qiagen
roch
use
seven
five
four
particip
respect
ptp
provid
insight
diagnost
methodolog
perform
laboratori
detect
worldwid
high
level
concord
particip
laboratori
suggest
high
global
capac
detect
despit
small
number
laboratori
perform
poorli
result
ptp
identifi
opportun
futur
improv
incorrect
result
could
attribut
three
main
caus
cross
contamin
ii
low
sensit
nat
predominantli
pcr
iii
transcript
error
number
laboratori
report
fals
posit
result
human
coronaviru
sampl
specimen
b
c
neg
sampl
specimen
result
report
high
c
valu
suggest
cross
contamin
sampl
four
particip
report
fals
neg
result
specimen
g
contain
lowest
concentr
particip
consist
report
unusu
high
c
valu
specimen
across
panel
indic
laboratori
rel
low
sensit
pcr
assay
may
abl
detect
lower
concentr
find
similar
two
previou
extern
qualiti
assess
report
laboratori
reduc
assay
sensit
assess
dilut
studi
also
demonstr
high
overal
capac
laboratori
detect
similarli
studi
perform
korean
outbreak
report
detect
score
amongst
howev
panel
studi
consist
three
specimen
limit
assess
assay
sensit
korean
chines
extern
qualiti
assess
differ
ptp
includ
human
coronavirus
assess
assay
specif
access
particip
futur
qualiti
assur
qa
program
provid
opportun
improv
technic
level
offer
ongo
ptp
detect
human
coronavirus
pcr
ensur
capac
remain
appropri
provid
continu
opportun
improv
result
detect
identif
human
coronavirus
less
conclus
laboratori
score
correctli
sampl
respect
howev
result
unsurpris
larg
proport
particip
report
limit
capabl
test
human
coronavirus
begin
ptp
capac
test
relat
organ
import
distinguish
pathogen
genet
relat
less
virul
organ
human
coronavirus
two
synthet
specimen
contain
complementari
dna
includ
ptp
provid
noninfecti
easili
access
scalabl
quantiti
target
analyt
although
specimen
score
inform
particip
laboratori
handl
equivoc
test
result
specimen
j
contain
five
vitro
transcrib
rna
transcript
design
intend
give
posit
result
nat
marker
includ
pcr
protocol
recommend
specimen
k
contain
singl
transcript
cover
upe
design
challeng
particip
sampl
would
yield
equivoc
result
particip
would
get
posit
result
initi
screen
assay
upe
confirmatori
test
initi
screen
would
neg
protocol
recommend
advis
specimen
collect
absenc
confirmatori
result
us
cdc
protocol
recommend
report
equivoc
result
contact
cdc
consult
context
ptp
expect
result
specimen
k
would
specifi
comment
equivoc
result
andor
necess
collect
test
second
sampl
interestingli
half
particip
laboratori
report
presenc
specimen
k
despit
fact
confirmatori
nat
assay
target
upe
neg
addit
small
number
laboratori
found
perform
averag
one
pcr
assay
per
sampl
result
highlight
need
laboratori
follow
nat
regimen
least
two
independ
assay
laboratori
need
detail
guidelin
pcr
test
interpret
well
report
instruct
address
issu
anticip
global
laboratori
capac
detect
enhanc
engag
intern
laboratori
especi
countri
limit
exposur
routin
qa
prove
one
major
challeng
organ
execut
ptp
languag
barrier
limit
resourc
skeptic
toward
unknown
organ
well
need
laboratori
continu
routin
test
alongsid
ptp
sampl
test
like
contribut
difficulti
engag
jurisdict
difficulti
specimen
handl
also
administr
challeng
despit
materi
infecti
sever
laboratori
requir
rang
document
import
permit
obtain
document
often
one
instanc
requir
week
longer
specimen
could
receiv
respons
challeng
need
includ
earli
engag
laboratori
much
local
interact
possibl
region
support
effect
commun
custom
courier
offici
avoid
delay
dispatch
stage
ptp
strong
support
region
offic
key
success
run
ptp
laboratori
countri
contract
three
differ
courier
servic
ensur
effici
distribut
ptp
global
laboratori
receiv
panel
within
day
dispatch
conclus
particip
laboratori
high
overal
capac
detect
ptp
identifi
improv
opportun
technic
level
includ
need
perform
confirmatori
nat
assay
ii
avoid
cross
contamin
sampl
iii
care
clear
identif
particular
coronaviru
target
result
laboratori
need
access
qa
program
continu
encourag
engag
qa
activ
addit
import
diagnost
function
facilit
involv
laboratori
appropri
qa
program
essenti
continu
accur
detect
pathogen
accur
diagnosi
critic
pathogen
infrequ
seen
detect
may
signific
commun
public
health
social
implic
continu
involv
qa
program
attent
technic
detail
staff
develop
avoid
signific
laboratori
error
unnecessari
public
health
concern
author
declar
conflict
interest
